No black box warning on record for Latanoprostene Bunod Ophthalmic Solution, 0.024%

As of the latest FDA labeling reviewed, Latanoprostene Bunod Ophthalmic Solution, 0.024% (LATANOPROSTENE BUNOD OPHTHALMIC SOLUTION, 0.024%) does not carry a black box warning. Standard warnings and precautions still apply — see the full Latanoprostene Bunod Ophthalmic Solution, 0.024% medicine page for the complete safety profile.

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS • Pigmentation: Increased pigmentation of the iris and periorbital tissue (eyelid) can occur. Iris pigmentation is likely to be permanent. ( 5.1 ) • Eyelash changes: Gradual changes to eyelashes including increased length, increased thickness and number of eyelashes. Usually reversible upon discontinuation of treatment. ( 5.2 ) 5.1 Pigmentation Latanoprostene bunod ophth

No black box warning on record for Latanoprostene Bunod Ophthalmic Solution, 0.024%

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS • Pigmentation: Increased pigmentation of the iris and periorbital tissue (eyelid) can occur. Iris pigmentation is likely to be permanent. ( 5.1 ) • Eyelash changes: Gradual changes to eyelashes including increased length, increased thickness and number of eyelashes. Usually reversible upon discontinuation of treatment. ( 5.2 ) 5.1 Pigmentation Latanoprostene bunod ophth

Latanoprostene Bunod Ophthalmic Solution, 0.024% Black Box Warning

No black box warning on record for Latanoprostene Bunod Ophthalmic Solution, 0.024%

Other warnings & precautions

Latanoprostene Bunod Ophthalmic Solution, 0.024% Black Box Warning

No black box warning on record for Latanoprostene Bunod Ophthalmic Solution, 0.024%

Other warnings & precautions